REQUEST A DEMO
Total
USD $0.00
Search more companies

Lekarna Na Namesti Dacice S.R.O. (Czech Republic)

Main Activities: Pharmacies and Drug Stores | Department Stores
Full name: Lekarna Na Namesti Dacice S.R.O. Profile Updated: August 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Lekarna Na Namesti Dacice S.R.O. is based in Czech Republic. The head office is in Ostrava. It operates in the Pharmacies and Drug Stores industry. The company was established on September 08, 2014. Lekarna Na Namesti Dacice S.R.O. currently employs 10 - 19 (2025) people. There was a net sales revenue drop of 12.9% reported in Lekarna Na Namesti Dacice S.R.O.’s latest financial highlights for 2025. Its’ total assets recorded a negative growth of 8.59%. The net profit margin of Lekarna Na Namesti Dacice S.R.O. increased by 3.05% in 2025.

Headquarters
Tesinska 1349/296
Ostrava; Moravskoslezsky; Postal Code: 71600

Contact Details: Purchase the Lekarna Na Namesti Dacice S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Lekarna Na Namesti Dacice S.R.O. report to view the information.
Registered Capital:
Purchase the Lekarna Na Namesti Dacice S.R.O. report to view the information.
Financial Auditors:
Purchase the Lekarna Na Namesti Dacice S.R.O. report to view the information.
Incorporation Date:
September 08, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Lekarna Na Namesti Dacice S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-12.9%
Total Operating Revenue
-12.9%
Operating Profit
90.64%
EBITDA
81.66%
Net Profit/Loss for the Period
107.44%
Total Assets
-8.59%
Total Equity
14.96%
Operating Profit Margin
3.77%
Net Profit Margin
3.05%
Return on Equity (ROE)
11.2%
Quick Ratio
3.98%
Cash Ratio
2.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?